These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21571335)

  • 1. The role of 3-dimensional mapping biopsy in decision making for treatment of apparent early stage prostate cancer.
    Barqawi AB; Rove KO; Gholizadeh S; O'Donnell CI; Koul H; Crawford ED
    J Urol; 2011 Jul; 186(1):80-5. PubMed ID: 21571335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management.
    Onik G; Miessau M; Bostwick DG
    J Clin Oncol; 2009 Sep; 27(26):4321-6. PubMed ID: 19652073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy.
    Crawford ED; Wilson SS; Torkko KC; Hirano D; Stewart JS; Brammell C; Wilson RS; Kawata N; Sullivan H; Lucia MS; Werahera PN
    BJU Int; 2005 Nov; 96(7):999-1004. PubMed ID: 16225516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience.
    Barzell WE; Melamed MR
    Urology; 2007 Dec; 70(6 Suppl):27-35. PubMed ID: 18194708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The independent impact of extended pattern biopsy on prostate cancer stage migration.
    Master VA; Chi T; Simko JP; Weinberg V; Carroll PR
    J Urol; 2005 Nov; 174(5):1789-93; discussion 1793. PubMed ID: 16217288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy.
    Numao N; Kawakami S; Yokoyama M; Yonese J; Arisawa C; Ishikawa Y; Ando M; Fukui I; Kihara K
    Eur Urol; 2007 Dec; 52(6):1663-8. PubMed ID: 17240041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
    Stewart CS; Leibovich BC; Weaver AL; Lieber MM
    J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging saturation biopsy in patients with prostate cancer on active surveillance protocol.
    Abouassaly R; Lane BR; Jones JS
    Urology; 2008 Apr; 71(4):573-7. PubMed ID: 18387385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of transition zone prostate cancer diagnosed by transperineal template-guided mapping biopsy: implications for treatment planning.
    Patel V; Merrick GS; Allen ZA; Andreini H; Taubenslag W; Singh S; Butler WM; Adamovich E; Bittner N
    Urology; 2011 May; 77(5):1148-52. PubMed ID: 21334045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
    Capitanio U; Karakiewicz PI; Valiquette L; Perrotte P; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F
    Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen.
    Emiliozzi P; Longhi S; Scarpone P; Pansadoro A; DePaula F; Pansadoro V
    J Urol; 2001 Sep; 166(3):845-50. PubMed ID: 11490231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the period between biopsy and diffusion-weighted magnetic resonance imaging on cancer staging in localized prostate cancer.
    Park KK; Lee SH; Lim BJ; Kim JH; Chung BH
    BJU Int; 2010 Oct; 106(8):1148-51. PubMed ID: 20346052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal sampling sites for repeat prostate biopsy: a recursive partitioning analysis of three-dimensional 26-core systematic biopsy.
    Kawakami S; Okuno T; Yonese J; Igari T; Arai G; Fujii Y; Kageyama Y; Fukui I; Kihara K
    Eur Urol; 2007 Mar; 51(3):675-82; discussion 682-3. PubMed ID: 16843585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
    Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
    J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On extended biopsy of the prostatic gland].
    Chepurov AK; Vladimirov VG; Zarinskaia SA; Meshkov VV; Kobaladze KM; Iremashvili VV
    Urologiia; 2010; (1):52-5. PubMed ID: 20886732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of prostate-specific antigen screening during the last decade: development of clinicopathological variables independently of the biopsy core number.
    Ploussard G; Azancot V; Nicolaiew N; Xylinas E; Salomon L; Allory Y; Vordos D; Hoznek A; Abbou CC; de la Taille A
    BJU Int; 2010 Nov; 106(9):1293-7. PubMed ID: 20456338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
    Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
    Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study of transrectal aspiration biopsy of the prostate].
    Fujioka T; Ishii N; Chiba R; Majima K; Numata I; Hakozaki H
    Hinyokika Kiyo; 1984 Sep; 30(9):1189-94. PubMed ID: 6524561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.